Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Daltonics Licenses Mass Spec Patent Portfolio to Waters

SAN FRANCISCO, Calif., Aug. 1 - Bruker Daltonics has licensed a portfolio of mass spectrometry patents to Waters, the companies said today.

 

The patents cover technologies that improve the accuracy and sensitivity in MALDI-TOF systems. The patents fall under Bruker Daltonics' portfolio of Space-Velocity Correlation Focusing patents owned by IndianaUniversity, Applied Biosystems, and Bruker Daltonics.

 

Waters received a sub-license in exchange for a one-time technology access fee and multi-year royalty payments, according to the companies.

 

Financial details of the agreement were not disclosed.

 

Click here for more information.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more